Back to Results
First PageMeta Content
Biology / Diabetes mellitus type 1 / Diabetes management / Latent autoimmune diabetes / Insulin therapy / Insulin / Diabetes mellitus / C-peptide / Muromonab-CD3 / Diabetes / Endocrine system / Medicine


A Single Course of Anti-CD3 Monoclonal Antibody hOKT3␥1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold,1 Stephen E. Gi
Add to Reading List

Document Date: 2005-05-10 10:04:46


Open Document

File Size: 149,19 KB

Share Result on Facebook
UPDATE